The U.S. FDA’s Unique Device Identification (UDI) Initiative
The UDI mandate, initiated in 2013 by the FDA, enabled better traceability of medical devices throughout the supply chain. Under this mandate, all medical devices sold in the U.S. were labeled with a Unique Device Identifier, which was also stored in the global UDI Database (GUDID). The regulation ensures the availability of accurate and reliable information for patients, providers, and public members, enabling visibility and transparency. In April 2016, the FDA UDI team conducted a conference in Baltimore to guide and train medical device manufacturers, healthcare providers, healthcare distribution groups, and healthcare industry professionals on how to comply with the new regulations.
High Cost of Implementation and Maintenance
The efficient utilization of healthcare supply chain management demands significant investments by hospitals and pharmacies. Small- to medium-sized hospitals and pharmacies find it difficult to afford such systems as they have controlled budgets and cannot justify long payback periods. The implementation of such software is time-consuming, which is a key concern as many hospitals are not comfortable operating for such long periods without minimum IT support. Such problems can be resolved by upgrading support and maintenance services that involve software upgrades as per changing consumer requirements, which represent a recurring expenditure amounting to almost 30% of the total cost of ownership.
Got questions about your regional growth of
Healthcare Supply Chain Market?
Just drop us a line or call on +1 646 480 7505
Healthcare Supply Chain Market Segmentation
By Delivery Mode
" Crucial Insights The Report Provides:"
* Known and Unknown Adjacencies Influencing the Growth of Market
* Explorable Revenue Sources
* Customer Behaviour Analysis
* Target Partners
* Customized Geographical Data Based on Customers as well as Competitors
* Analysis of Market Size and CAGR between the Forecast PeriodsView Full Report Buy This Report Now